Natick, MA, United States of America

Roger L Xie


Average Co-Inventor Count = 7.7

ph-index = 3

Forward Citations = 65(Granted Patents)


Location History:

  • Westborough, MA (US) (2000)
  • Natrick, MA (US) (2004)
  • Natick, MA (US) (2001 - 2010)

Company Filing History:


Years Active: 2000-2010

Loading Chart...
7 patents (USPTO):

Title: The Innovative Contributions of Roger L. Xie

Introduction

Roger L. Xie is a prominent inventor based in Natick, MA (US). He has made significant contributions to the field of chemistry, particularly in the synthesis of pharmaceutical compounds. With a total of 7 patents to his name, Xie's work has the potential to impact the treatment of various ailments.

Latest Patents

One of Roger L. Xie's latest patents focuses on methods for the stereoselective synthesis of substituted piperidines. This invention encompasses various aspects, including the synthesis of compounds that are useful for treating numerous ailments, conditions, and diseases that afflict mammals, such as addiction and pain. Additionally, the patent discusses the synthesis of combinatorial libraries of substituted piperidines and enantiomerically substituted pyrrolidines, piperidines, and azepines.

Career Highlights

Roger L. Xie is currently associated with Sepracor, Inc., where he continues to innovate and develop new methods in the field of chemistry. His work is characterized by a commitment to advancing pharmaceutical research and improving treatment options for patients.

Collaborations

Throughout his career, Xie has collaborated with notable colleagues, including Gregory D. Cuny and James R. Hauske. These collaborations have further enriched his research and contributed to the success of his inventions.

Conclusion

Roger L. Xie's innovative work in the synthesis of pharmaceutical compounds demonstrates his dedication to advancing medical science. His contributions are poised to make a significant impact on the treatment of various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…